These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 18992772

  • 1. Rapid determination of antiviral drug susceptibility of human cytomegalovirus by real-time PCR.
    Schnepf N, Boiteau N, Petit F, Alain S, Sanson-Le Pors MJ, Mazeron MC.
    Antiviral Res; 2009 Jan; 81(1):64-7. PubMed ID: 18992772
    [Abstract] [Full Text] [Related]

  • 2. The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay.
    Eckle T, Jahn G, Hamprecht K.
    J Clin Virol; 2004 May; 30(1):50-6. PubMed ID: 15072754
    [Abstract] [Full Text] [Related]

  • 3. Real-time PCR determination of human herpesvirus 6 antiviral drug susceptibility.
    Isegawa Y, Takemoto M, Yamanishi K, Ohshima A, Sugimoto N.
    J Virol Methods; 2007 Mar; 140(1-2):25-31. PubMed ID: 17156861
    [Abstract] [Full Text] [Related]

  • 4. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
    Thi TN, Deback C, Malet I, Bonnafous P, Ait-Arkoub Z, Agut H.
    Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859
    [Abstract] [Full Text] [Related]

  • 5. Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance.
    Göhring K, Mikeler E, Jahn G, Rohde F, Hamprecht K.
    Antivir Ther; 2008 Mar; 13(3):461-6. PubMed ID: 18572760
    [Abstract] [Full Text] [Related]

  • 6. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay.
    Gouarin S, Vabret A, Gault E, Petitjean J, Regeasse A, Hurault de Ligny B, Freymuth F.
    J Clin Virol; 2004 Mar; 29(3):194-201. PubMed ID: 14962789
    [Abstract] [Full Text] [Related]

  • 7. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
    Scott GM, Isaacs MA, Zeng F, Kesson AM, Rawlinson WD.
    J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
    [Abstract] [Full Text] [Related]

  • 8. Contrasting effects on ganciclovir susceptibility and replicative capacity of two mutations at codon 466 of the human cytomegalovirus UL97 gene.
    Martin M, Goyette N, Boivin G.
    J Clin Virol; 2010 Dec; 49(4):296-8. PubMed ID: 20843736
    [Abstract] [Full Text] [Related]

  • 9. Development of SYBR Green I-based real-time PCR assay for detection of drug resistance mutations in cytomegalovirus.
    Liu JB, Zhang Z.
    J Virol Methods; 2008 Apr; 149(1):129-35. PubMed ID: 18280587
    [Abstract] [Full Text] [Related]

  • 10. Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia.
    Mengelle C, Pasquier C, Rostaing L, Sandres-Sauné K, Puel J, Berges L, Righi L, Bouquies C, Izopet J.
    J Med Virol; 2003 Feb; 69(2):225-31. PubMed ID: 12683412
    [Abstract] [Full Text] [Related]

  • 11. [In vitro susceptibility to ganciclovir and foscarnet of cytomegaloviruses].
    Otegui M, Rabella N, Labeaga R, Herrero M, Margall R, Muñoz JM, Prats G.
    Rev Esp Quimioter; 2001 Jun; 14(2):155-64. PubMed ID: 11704769
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of human cytomegalovirus to two-drug combinations in vitro.
    Manion DJ, Vibhagool A, Chou TC, Kaplan J, Caliendo A, Hirsch MS.
    Antivir Ther; 1996 Dec; 1(4):237-45. PubMed ID: 11324826
    [Abstract] [Full Text] [Related]

  • 13. Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact.
    Baldanti F, Gerna G.
    J Antimicrob Chemother; 2003 Sep; 52(3):324-30. PubMed ID: 12888590
    [Abstract] [Full Text] [Related]

  • 14. [Resistance of cytomegalovirus to ganciclovir: rapid detection of the mutations 460 of the UL97 phosphotransferase].
    Alain S, Mazeron MC, Vadam C, Honderlick P, Thouvenot D, Freymuth F, Fillet AM, Carquin J, Sanson-Le Pors MJ.
    Pathol Biol (Paris); 1996 May; 44(5):456-60. PubMed ID: 8758494
    [Abstract] [Full Text] [Related]

  • 15. A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains.
    Prix L, Maierl J, Jahn G, Hamprecht K.
    J Clin Virol; 1998 Jul 24; 11(1):29-37. PubMed ID: 9784141
    [Abstract] [Full Text] [Related]

  • 16. Molecular analysis of the human cytomegalovirus strains isolated from infected infants.
    Augustynowicz E, Dzierzanowska D.
    Acta Microbiol Pol; 1998 Jul 24; 47(4):373-83. PubMed ID: 10333560
    [Abstract] [Full Text] [Related]

  • 17. New reporter cell line to evaluate the sequential emergence of multiple human cytomegalovirus mutations during in vitro drug exposure.
    Gilbert C, Boivin G.
    Antimicrob Agents Chemother; 2005 Dec 24; 49(12):4860-6. PubMed ID: 16304146
    [Abstract] [Full Text] [Related]

  • 18. Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells.
    Michaelis M, Ha TA, Doerr HW, Cinatl J.
    Cardiovasc Res; 2008 Feb 01; 77(3):544-50. PubMed ID: 18006438
    [Abstract] [Full Text] [Related]

  • 19. A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet.
    Ducancelle A, Champier G, Alain S, Petit F, Le Pors MJ, Mazeron MC.
    Antivir Ther; 2006 Feb 01; 11(4):537-40. PubMed ID: 16856628
    [Abstract] [Full Text] [Related]

  • 20. Antiviral activity of ganciclovir and artesunate towards human cytomegalovirus in astrocytoma cells.
    Schnepf N, Corvo J, Pors MJ, Mazeron MC.
    Antiviral Res; 2011 Feb 01; 89(2):186-8. PubMed ID: 21167209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.